Marcus Schulz's most recent trade in Biolife Solutions Inc was a trade of 347 Common Stock done at an average price of $11.0 . Disclosure was reported to the exchange on Aug. 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 10.99 per share. | 25 Aug 2023 | 347 | 42,097 (0%) | 0% | 11.0 | 3,814 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 14 Aug 2023 | 108 | 42,444 (0%) | 0% | 12.4 | 1,337 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 24 Jul 2023 | 679 | 42,552 (0%) | 0% | 19.5 | 13,241 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 22.79 per share. | 11 Jul 2023 | 331 | 43,231 (0%) | 0% | 22.8 | 7,543 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 23.21 per share. | 31 May 2023 | 337 | 43,562 (0%) | 0% | 23.2 | 7,822 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 18.71 per share. | 15 May 2023 | 75 | 43,899 (0%) | 0% | 18.7 | 1,403 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 19.33 per share. | 19 Apr 2023 | 430 | 41,062 (0%) | 0% | 19.3 | 8,312 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 21.05 per share. | 14 Apr 2023 | 215 | 41,492 (0%) | 0% | 21.1 | 4,526 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,912 | 0 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,912 | 45,390 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 31 Mar 2023 | 771 | 44,619 (0%) | 0% | 20.0 | 15,443 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 01 Mar 2023 | 903 | 42,478 (0%) | 0% | 22.7 | 20,543 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 24.61 per share. | 09 Feb 2023 | 56 | 43,381 (0%) | 0% | 24.6 | 1,378 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 23 Jan 2023 | 1,000 | 43,437 (0%) | 0% | 25.0 | 25,020 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 18 Jan 2023 | 3,000 | 44,975 (0%) | 0% | 25.0 | 75,120 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 22.93 per share. | 18 Jan 2023 | 538 | 44,437 (0%) | 0% | 22.9 | 12,336 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 21.94 per share. | 11 Jan 2023 | 258 | 47,975 (0%) | 0% | 21.9 | 5,661 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,733 | 12,733 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,733 | 48,233 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 23.15 per share. | 10 Nov 2022 | 40 | 35,500 (0%) | 0% | 23.2 | 926 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 21.76 per share. | 28 Oct 2022 | 400 | 35,540 (0%) | 0% | 21.8 | 8,704 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 21.80 per share. | 14 Oct 2022 | 236 | 35,940 (0%) | 0% | 21.8 | 5,145 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 10 Aug 2022 | 42 | 36,176 (0%) | 0% | 23.2 | 973 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 17.94 per share. | 22 Jul 2022 | 367 | 40,818 (0%) | 0% | 17.9 | 6,584 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 15.79 per share. | 12 Jul 2022 | 254 | 41,185 (0%) | 0% | 15.8 | 4,011 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 12.32 per share. | 13 May 2022 | 41 | 41,439 (0%) | 0% | 12.3 | 505 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 17.59 per share. | 18 Apr 2022 | 286 | 41,957 (0%) | 0% | 17.6 | 5,031 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 14,019 | 14,019 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 14,019 | 42,243 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 29.38 per share. | 10 Feb 2022 | 167 | 28,224 (0%) | 0% | 29.4 | 4,906 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 30.24 per share. | 20 Jan 2022 | 395 | 28,391 (0%) | 0% | 30.2 | 11,945 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 32.18 per share. | 12 Jan 2022 | 267 | 28,786 (0%) | 0% | 32.2 | 8,592 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 11 Oct 2021 | 245 | 31,202 (0%) | 0% | 38.2 | 9,364 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 45.48 per share. | 26 Jul 2021 | 4,269 | 32,097 (0%) | 0% | 45.5 | 194,154 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 46.78 per share. | 26 Jul 2021 | 650 | 31,447 (0%) | 0% | 46.8 | 30,407 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 45.10 per share. | 20 Jul 2021 | 2,539 | 36,366 (0%) | 0% | 45.1 | 114,509 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 20 Apr 2021 | 650 | 39,145 (0%) | 0% | 32.1 | 20,865 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 35.77 per share. | 08 Apr 2021 | 224 | 39,795 (0%) | 0% | 35.8 | 8,012 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 41.01 per share. | 12 Feb 2021 | 2,000 | 37,107 (0%) | 0% | 41.0 | 82,020 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 2,912 | 2,912 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Marcus Schulz | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 2,912 | 40,019 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Marcus Schulz | Vice President, Global Sales | Sale of securities on an exchange or to another person at price $ 39.01 per share. | 08 Jan 2021 | 293 | 39,107 (0%) | 0% | 39.0 | 11,430 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Vice President, Global Sales | Sale of securities on an exchange or to another person at price $ 32.51 per share. | 12 Nov 2020 | 1,400 | 39,400 (0%) | 0% | 32.5 | 45,514 | Common Stock |
| Biolife Solutions Inc | Marcus Schulz | Vice President, Global Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2020 | 26,624 | 41,753 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Marcus Schulz | Vice President, Global Sales | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 17 Jul 2020 | 953 | 40,800 (0%) | 0% | 28.2 | 26,875 | Common Stock |